Sun Pharma shares in green today after report of company in talks to buy Organon of US
By Ankur Chandra | Updated at: Jan 19, 2026 01:37 PM IST
Sun Pharma shares are up by 0.49% at 12:05 p.m. IST, 19th January, 2026. Nifty 50 index is down by 0.67% at this time. Nifty Pharma index is down by 0.37% at this time. Sun Pharma has the biggest weight, at 22.06%, currently in this index. This implies that at this time today, Sun Pharma shares are gaining more than the shares of other industry peers.
Sun Pharma may be in talks to acquire Organon
A media report has come today that Sun Pharma is in talks to buy Organon of US for an enterprise value of around $10 billion. Organon is listed at New York Stock Exchange (NYSE). Its main products include pharmaceutical products for women, biosimilars etc. These products include contraceptive products, fertility products etc. The company also has an expanding presence in biosimilars. Organon posted a profit of $160 million in the September 2025 quarter. Its earnings per share in the quarter stood at $0.61 per share. Revenues in the quarter stood at $1.602 billion. Organon currently has debt of $8.9 billion on its balance sheet. The interest payments on this debt may be eating into the profit margin of the company.
With increased protectionism in US, having more onshore presence there through acquisition of US companies may become part of the strategy of many more Indian pharma companies.
Organon shares have lost more than 44% in the past 1 year
Organon shares ended the day on Friday, 16th January, up by 0.67% at $8.76 per share. In the past 1 year Organon shares have lost around 44.84%. NYSE composite has gained 14.65% in this period. Organon’s stock has underperformed the Nasdaq Composite by more than 58% in the past 1 year. The stock is currently trading at a Price-to-Earnings (P/E) ratio of just 4.55. Sun Pharma shares are currently trading at a 12-month trailing P/E ratio of around 38.
Disclaimer : This content is only for informational purpose. It does not make any recommendation to act or invest.
Source: NSE, Organon https://www.organon.com/news/organon-reports-results-for-the-third-quarter-ended-september-30-2025/
